Showing results (461-470 of 1,900) with videos related to

Sort By:
Pageof 190
Scientific Reports|July 18, 2025
miRNA-338-3p influences the liver cancer stem cells and lenvatinib resistance properties by targeting SOX4Ying Yuan, Hui-Fen Li, Zi-Mei Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2025
Practical Considerations for Using the TITE-BOIN Design to Handle Late-onset Toxicity or Fast Accrual in Phase I TrialsKai Chen, Ting-Yu Chen, Yiming Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2016
Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology TrialsYing Yuan, Kenneth R Hess, Susan G Hilsenbeck, et al.
Optics Express|October 19, 2017
Electrically optofluidic zoom system with a large zoom range and high-resolution imageLei Li, Rong-Ying Yuan, Jin-Hui Wang, et al.
Neural Regeneration Research|December 13, 2018
Association of G-protein coupled purinergic receptor P2Y2 with ischemic stroke in a Han Chinese population of North ChinaLi-Ying Yuan, Zhi-Yi He, Lei Li, et al.
Huan Jing Ke Xue= Huanjing Kexue|August 3, 2006
[Impact of pH on the generation of COD, phosphorous and ammonia-nitrogen during the anaerobic fermentation of excess activated sludge]Hong-ying Yuan, Hua-xing Zhang, Yin-guang Chen, et al.
Biotechnology Letters|November 16, 2011
Fusion of HSA influences TNF-α neutralizing activity of shTNFRsJia Zhan, Ying Chen, Han-Ying Yuan, et al.
World Journal of Oncology|November 18, 2017
Serum Protein Pattern Could Predict the Therapeutic Effect of First-Line Pemetrexed/Cisplatin Chemotherapy in Patients With Lung AdenocarcinomaHong Shen, Xue-Feng Fang, Ying Yuan, et al.
Frontiers in Genetics|July 7, 2022
RNA-Seq and Gene Ontology Analysis Reveal Differences Associated With Low R/FR-Induced Shade Responses in Cultivated Lentil and a Wild RelativeHai Ying Yuan, Carolyn T Caron, Albert Vandenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I TrialsYing Yuan, Ruitao Lin, Daniel Li, et al.
Pageof 190